Page last updated: 2024-08-21

diepoxybutane and Hematologic Diseases

diepoxybutane has been researched along with Hematologic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Friedl, R; Hentze, S; Hoehn, H; Schindler, D; Schroeder-Kurth, T; Seyschab, H; Sun, Y	1

Other Studies

1 other study(ies) available for diepoxybutane and Hematologic Diseases

Article	Year
Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood, 1995, Apr-15, Volume: 85, Issue:8 Topics: Cells, Cultured; Chromosome Aberrations; Chromosomes; Cross-Linking Reagents; Drug Resistance; Epoxy Compounds; Fanconi Anemia; Flow Cytometry; G2 Phase; Hematologic Diseases; Humans; Lymphocyte Activation; Lymphocytes; Mitomycin; Mutagens; Single-Blind Method	1995

Article

Year

Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia.

Blood, 1995, Apr-15, Volume: 85, Issue:8

Topics: Cells, Cultured; Chromosome Aberrations; Chromosomes; Cross-Linking Reagents; Drug Resistance; Epoxy Compounds; Fanconi Anemia; Flow Cytometry; G2 Phase; Hematologic Diseases; Humans; Lymphocyte Activation; Lymphocytes; Mitomycin; Mutagens; Single-Blind Method

1995